Alamar Capital Management LLC Purchases New Shares in Tenet Healthcare Corporation $THC

Alamar Capital Management LLC acquired a new position in shares of Tenet Healthcare Corporation (NYSE:THC) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 11,112 shares of the company’s stock, valued at approximately $2,097,000. Tenet Healthcare accounts for about 1.3% of Alamar Capital Management LLC’s holdings, making the stock its 23rd biggest holding.

Several other hedge funds and other institutional investors have also made changes to their positions in THC. Lido Advisors LLC purchased a new position in shares of Tenet Healthcare during the 1st quarter worth about $427,000. First Trust Advisors LP raised its position in Tenet Healthcare by 11.8% in the 1st quarter. First Trust Advisors LP now owns 240,019 shares of the company’s stock worth $45,294,000 after purchasing an additional 25,263 shares during the period. PNC Financial Services Group Inc. lifted its stake in Tenet Healthcare by 10.5% in the first quarter. PNC Financial Services Group Inc. now owns 6,086 shares of the company’s stock worth $1,148,000 after purchasing an additional 580 shares during the last quarter. Parallel Advisors LLC boosted its position in shares of Tenet Healthcare by 108.9% during the first quarter. Parallel Advisors LLC now owns 1,389 shares of the company’s stock valued at $262,000 after buying an additional 724 shares during the period. Finally, Hanseatic Management Services Inc. purchased a new stake in shares of Tenet Healthcare in the first quarter worth approximately $326,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Insider Activity

In other news, Director J Robert Kerrey sold 5,638 shares of the business’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the sale, the director owned 16,804 shares in the company, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Nadja West sold 3,000 shares of the stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the transaction, the director owned 24,805 shares in the company, valued at approximately $4,399,166.75. This represents a 10.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.97% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. Weiss Ratings cut Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 2nd. Royal Bank Of Canada reduced their target price on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a research note on Friday, May 1st. Guggenheim lowered their target price on shares of Tenet Healthcare from $252.00 to $242.00 and set a “buy” rating for the company in a research note on Monday. Stephens reduced their price target on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Finally, KeyCorp decreased their price objective on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Seventeen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $244.84.

Tenet Healthcare Price Performance

Shares of THC stock opened at $195.84 on Thursday. Tenet Healthcare Corporation has a twelve month low of $146.60 and a twelve month high of $247.21. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The stock has a fifty day simple moving average of $184.41 and a two-hundred day simple moving average of $197.37. The stock has a market capitalization of $16.87 billion, a price-to-earnings ratio of 10.18, a P/E/G ratio of 1.63 and a beta of 1.27.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, beating the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. During the same quarter last year, the firm posted $4.36 earnings per share. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, analysts predict that Tenet Healthcare Corporation will post 17.5 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.